These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36867374)

  • 1. Predictors of mortality in heart failure with reduced ejection fraction: interaction between diabetes mellitus and impaired renal function.
    Yang Y; Huang Z; Wu B; Lu J; Xiu J; Tu J; Chen S; Pan Y; Bao K; Wang J; Chen W; Liu J; Liu Y; Chen S; Chen K; Chen L
    Int Urol Nephrol; 2023 Sep; 55(9):2285-2293. PubMed ID: 36867374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of interaction of diabetes mellitus with chronic kidney disease on mortality in acute heart failure.
    de Miguel-Yanes JM; Méndez-Bailón M; Marco-Martínez J; Zapatero-Gaviria A; Barba-Martín R
    Ren Fail; 2014 Nov; 36(10):1536-40. PubMed ID: 25211320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
    Chao CT; Lee SY; Wang J; Chien KL; Hung KY
    Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
    Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
    BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-renal-metabolic syndrome: clinical features and dapagliflozin eligibility in a real-world heart failure cohort.
    Beles M; Masuy I; Verstreken S; Bartunek J; Dierckx R; Heggermont W; Oeste C; De Boeck M; Fovel I; Maris M; Vermeulen Z; Vanderheyden M
    ESC Heart Fail; 2023 Aug; 10(4):2269-2280. PubMed ID: 37095712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure.
    Ritchie C; Ekundayo OJ; Muchimba M; Campbell RC; Frank SJ; Liu B; Aban IB; Ahmed A
    Int J Cardiol; 2009 May; 134(3):330-5. PubMed ID: 19178965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
    Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
    Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease.
    Li CH; Lee CL; Hsieh YC; Chen CH; Wu MJ; Tsai SF
    BMC Nephrol; 2022 Apr; 23(1):157. PubMed ID: 35459096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate and joint effects of diabetes mellitus and chronic kidney disease on the risk of acute coronary syndrome: a population-based cohort study.
    Chang YT; Liu CC; Tsai LM; Li CY; Sung JM
    Medicine (Baltimore); 2014 Dec; 93(28):e261. PubMed ID: 25526451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.
    Hirata A; Okamura T; Sugiyama D; Kuwabara K; Kadota A; Fujiyoshi A; Miura K; Okuda N; Ohkubo T; Okayama A; Ueshima H;
    Eur J Prev Cardiol; 2017 Mar; 24(5):505-513. PubMed ID: 27856810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.
    Nayor M; Larson MG; Wang N; Santhanakrishnan R; Lee DS; Tsao CW; Cheng S; Benjamin EJ; Vasan RS; Levy D; Fox CS; Ho JE
    Eur J Heart Fail; 2017 May; 19(5):615-623. PubMed ID: 28217978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study.
    Kong MG; Jang SY; Jang J; Cho HJ; Lee S; Lee SE; Kim KH; Yoo BS; Kang SM; Baek SH; Choi DJ; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Lim S; Park SK; Lee HY
    Cardiovasc Diabetol; 2020 May; 19(1):49. PubMed ID: 32359358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
    Streng KW; Nauta JF; Hillege HL; Anker SD; Cleland JG; Dickstein K; Filippatos G; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Damman K; van der Meer P; Voors AA
    Int J Cardiol; 2018 Nov; 271():132-139. PubMed ID: 30482453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D deficiency--prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis--a prospective multicenter study.
    Schiller A; Gadalean F; Schiller O; Timar R; Bob F; Munteanu M; Stoian D; Mihaescu A; Timar B
    PLoS One; 2015; 10(5):e0126586. PubMed ID: 25965403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes.
    Wu MZ; Teng TK; Tay WT; Ren QW; Tromp J; Ouwerkerk W; Chandramouli C; Huang JY; Chan YH; Teramoto K; Yu SY; Lawson C; Li HL; Tse YK; Li XL; Hung D; Tse HF; Lam CSP; Yiu KH
    Diabetes Obes Metab; 2023 Mar; 25(3):707-715. PubMed ID: 36346045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between body mass index and survival in Taiwanese heart failure patients with and without diabetes mellitus.
    Lu YY; Wu VCC; Chu PH; Ho CT; Chang CY
    Medicine (Baltimore); 2021 Dec; 100(48):e28114. PubMed ID: 35049240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Failure in Patients with Diabetes and Chronic Kidney Disease: Challenges and Opportunities.
    Vijay K; Neuen BL; Lerma EV
    Cardiorenal Med; 2022; 12(1):1-10. PubMed ID: 34802000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.